Biosig announces purchase agreement with kansas city heart rhythm institute at overland park regional medical center

Westport, ct, july 07, 2022 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that kansas city heart institute at overland park regional medical center in kansas city, u.s. has signed a purchase agreement to acquire its pure ep(t.m.) system.
BSGM Ratings Summary
BSGM Quant Ranking